Seungtaek Kim to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Seungtaek Kim has written about Dose-Response Relationship, Drug.
Connection Strength
0.134
-
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells. J Med Virol. 2021 03; 93(3):1403-1408.
Score: 0.107
-
Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2. Bioorg Med Chem Lett. 2021 01 01; 31:127667.
Score: 0.027